Myriad — Under The Microscope

Law360, New York (August 17, 2012, 4:55 PM EDT) -- On Aug. 16, 2012, the U.S. Court of Appeals for the Federal Circuit decided Association for Molecular Pathology v. Myriad Genetics Inc., No. 2010-1406, on remand from the U.S. Supreme Court to consider the impact of Mayo Collaborative Services v. Prometheus Inc., 566 U.S. ___, 132 S. Ct. 1289 (2012). As explained below, the Federal Circuit’s ruling largely aligns with the same panel’s previously vacated July 29, 2011, decision.

On the threshold issue of jurisdiction, the court reaffirmed the district court’s decision to exercise declaratory judgment...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.